DK1926483T3 - Behandling af autoimmune sygdomme - Google Patents

Behandling af autoimmune sygdomme

Info

Publication number
DK1926483T3
DK1926483T3 DK06793341.6T DK06793341T DK1926483T3 DK 1926483 T3 DK1926483 T3 DK 1926483T3 DK 06793341 T DK06793341 T DK 06793341T DK 1926483 T3 DK1926483 T3 DK 1926483T3
Authority
DK
Denmark
Prior art keywords
autoimmune diseases
treatment
neuritis
uveitis
invention describes
Prior art date
Application number
DK06793341.6T
Other languages
English (en)
Inventor
Rainer Albert
Nigel Graham Cooke
Barbara Nuesslein-Hildesheim
Sven Weiler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1926483T3 publication Critical patent/DK1926483T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06793341.6T 2005-09-09 2006-09-07 Behandling af autoimmune sygdomme DK1926483T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71599005P 2005-09-09 2005-09-09
PCT/EP2006/066150 WO2007028821A2 (en) 2005-09-09 2006-09-07 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
DK1926483T3 true DK1926483T3 (da) 2011-03-14

Family

ID=37056992

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10174280.7T DK2295049T3 (da) 2005-09-09 2006-09-07 Behandling af autoimmunsygdomme
DK06793341.6T DK1926483T3 (da) 2005-09-09 2006-09-07 Behandling af autoimmune sygdomme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10174280.7T DK2295049T3 (da) 2005-09-09 2006-09-07 Behandling af autoimmunsygdomme

Country Status (29)

Country Link
US (1) US20080200438A1 (da)
EP (2) EP1926483B1 (da)
JP (4) JP5244598B2 (da)
KR (3) KR20140117704A (da)
CN (1) CN101257899B (da)
AT (1) ATE489948T1 (da)
AU (2) AU2006289100B2 (da)
BR (1) BRPI0615906A2 (da)
CA (2) CA2620554C (da)
CY (1) CY1111285T1 (da)
DE (1) DE602006018629D1 (da)
DK (2) DK2295049T3 (da)
ES (2) ES2529724T3 (da)
HK (1) HK1149906A1 (da)
IL (2) IL189665A (da)
JO (1) JO2655B1 (da)
MA (1) MA29787B1 (da)
MX (1) MX2008003170A (da)
NO (1) NO20081727L (da)
NZ (2) NZ566137A (da)
PL (2) PL2295049T3 (da)
PT (2) PT1926483E (da)
RU (2) RU2493840C2 (da)
SG (1) SG165364A1 (da)
SI (2) SI1926483T1 (da)
TN (1) TNSN08103A1 (da)
TW (2) TWI372620B (da)
WO (1) WO2007028821A2 (da)
ZA (1) ZA200801694B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101178318B1 (ko) * 2004-07-16 2012-08-29 교린 세이야꾸 가부시키 가이샤 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법
EP1806338B1 (en) 2004-10-12 2016-01-20 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof
AU2006300485B2 (en) * 2005-10-07 2011-08-25 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
NZ574012A (en) * 2006-08-08 2012-02-24 Kyorin Seiyaku Kk Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
US8232319B2 (en) * 2006-08-08 2012-07-31 Kyorin Pharmaceutical Co., Ltd. Amino phosphate derivative and S1P receptor modulator having same as an active ingredient
JP5198293B2 (ja) * 2007-02-13 2013-05-15 杏林製薬株式会社 アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
WO2009099174A1 (ja) 2008-02-07 2009-08-13 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤
JPWO2009142195A1 (ja) * 2008-05-20 2011-09-29 杏林製薬株式会社 寛解導入維持剤
MX2011001881A (es) * 2008-08-18 2011-05-30 Novartis Ag Derivados de amino-alcohol para el tratamiento de neuropatias perifericas desmielinizantes.
MA34285B1 (fr) * 2010-05-06 2013-06-01 Novartis Ag Traitement de maladies autoimmunes
WO2011138398A1 (en) * 2010-05-06 2011-11-10 Novartis Ag Dosage regimen of diaryl sulfide derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141421A (en) * 1991-12-17 1992-08-25 Carrier Corporation Nested coupling mechanism for scroll machines
DE4428835A1 (de) * 1994-08-01 1996-02-08 Schering Ag Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
CA2282378C (en) * 1997-02-27 2008-12-30 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition
US6960692B2 (en) * 2001-09-27 2005-11-01 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
WO2003029184A1 (fr) 2001-09-27 2003-04-10 Kyorin Pharmaceutical Co., Ltd. Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur
BR0314455A (pt) * 2002-09-19 2005-07-26 Kyorin Seiyaku Kk Derivados de aminoálcool, seus sais e agentes imunosupressores
KR20050054958A (ko) * 2002-09-24 2005-06-10 노파르티스 아게 탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트수용체 아고니스트
CA2499882C (en) * 2002-09-28 2010-11-09 Mcneil-Ppc, Inc. Modified release dosage form with two cores
CN100344638C (zh) * 2003-02-18 2007-10-24 杏林制药株式会社 氨基膦酸衍生物、其加成盐以及s1p受体调节剂
KR20050121712A (ko) * 2003-04-08 2005-12-27 노파르티스 아게 유기 화합물
TW200505416A (en) * 2003-08-12 2005-02-16 Mitsubishi Pharma Corp Bi-aryl compound having immunosuppressive activity
CA2535704C (en) * 2003-08-28 2012-12-11 Novartis Ag Aminopropanol derivatives
KR101178318B1 (ko) * 2004-07-16 2012-08-29 교린 세이야꾸 가부시키 가이샤 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법
RU2478384C2 (ru) * 2004-11-29 2013-04-10 Новартис Аг Курс лечения с использованием агониста рецептора s1p
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
PL2295049T3 (pl) 2015-04-30
WO2007028821A2 (en) 2007-03-15
MX2008003170A (es) 2008-03-18
HK1149906A1 (en) 2011-10-21
RU2493840C2 (ru) 2013-09-27
IL189665A0 (en) 2008-06-05
ES2529724T3 (es) 2015-02-25
RU2008113187A (ru) 2009-10-20
KR101476451B1 (ko) 2014-12-24
CA2820510A1 (en) 2007-03-15
EP2295049A1 (en) 2011-03-16
NO20081727L (no) 2008-06-06
CN101257899A (zh) 2008-09-03
JP5244598B2 (ja) 2013-07-24
CA2620554A1 (en) 2007-03-15
TNSN08103A1 (en) 2009-07-14
JP2015025002A (ja) 2015-02-05
EP1926483A2 (en) 2008-06-04
TW200803829A (en) 2008-01-16
CN101257899B (zh) 2012-10-03
MA29787B1 (fr) 2008-09-01
JP2009507810A (ja) 2009-02-26
KR101476591B1 (ko) 2014-12-24
US20080200438A1 (en) 2008-08-21
KR20080046231A (ko) 2008-05-26
KR20140117704A (ko) 2014-10-07
PL1926483T3 (pl) 2011-05-31
CA2620554C (en) 2013-12-17
PT2295049E (pt) 2015-03-02
IL189665A (en) 2014-07-31
JP2017019854A (ja) 2017-01-26
SG165364A1 (en) 2010-10-28
RU2011111117A (ru) 2012-09-27
CY1111285T1 (el) 2015-08-05
NZ588372A (en) 2012-03-30
ZA200801694B (en) 2009-09-30
ATE489948T1 (de) 2010-12-15
DK2295049T3 (da) 2015-02-23
JP6077265B2 (ja) 2017-02-08
RU2424795C2 (ru) 2011-07-27
SI1926483T1 (sl) 2011-04-29
JO2655B1 (en) 2012-06-17
IL233328A0 (en) 2014-08-31
KR20140019033A (ko) 2014-02-13
TWI376223B (en) 2012-11-11
TW201034659A (en) 2010-10-01
NZ566137A (en) 2011-05-27
DE602006018629D1 (de) 2011-01-13
JP2013010802A (ja) 2013-01-17
PT1926483E (pt) 2011-03-03
TWI372620B (en) 2012-09-21
BRPI0615906A2 (pt) 2011-05-31
AU2006289100B2 (en) 2010-07-22
AU2010224355B2 (en) 2012-03-29
SI2295049T1 (sl) 2015-03-31
WO2007028821A3 (en) 2007-05-03
ES2357426T3 (es) 2011-04-26
EP1926483B1 (en) 2010-12-01
AU2010224355A1 (en) 2010-10-14
EP2295049B1 (en) 2014-11-26
AU2006289100A1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
DK1926483T3 (da) Behandling af autoimmune sygdomme
TW200509892A (en) Novel aminobenzophenone compounds
ATE478863T1 (de) Heterotetracyclische verbindungen als tpo- mimetica
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
DK1776349T3 (da) 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE)
EA201070247A1 (ru) Ингибиторы протеасом
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
NO20072092L (no) Sulfonamidforbindelser
EA200802054A1 (ru) Ингибиторы фермента
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
EA201000494A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
WO2006078576A3 (en) Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
MX2011012015A (es) Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
EA201170344A1 (ru) Азаиндольные ингибиторы iap
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
BRPI0512732A (pt) formulações tópicas para tratamento de doenças alérgicas
EA200701815A1 (ru) 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
WO2009051661A3 (en) Substituted aryl alkylamino-oxy-analogs and uses thereof